The largest database of trusted experimental protocols

Scleraxis

Manufactured by Santa Cruz Biotechnology
Sourced in United States

Scleraxis is a high-quality lab equipment product designed for use in scientific research. It serves as a tool for monitoring and analyzing the expression of the scleraxis gene, which plays a crucial role in the development and differentiation of tendon and ligament tissues. The core function of Scleraxis is to provide researchers with accurate and reliable data on the expression patterns of this important regulatory gene.

Automatically generated - may contain errors

2 protocols using scleraxis

1

Quantitative Analysis of Aortic Extracellular Matrix Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein samples from the thoracic aorta were prepared in lysis buffer as described previously [11 (link), 41 (link)–47 (link)]. The proteins (15 μg) were separated by SDS–PAGE and transferred onto nitrocellulose membrane (Bio-Rad). The membrane was then incubated overnight (4 °C) with a primary antibody against Collagen I (1:1000, Sigma–Aldrich), elastin (1:200, Santa Cruz Biotechnology), TGFβ−1(1:100, Santa Cruz Biotechnology), scleraxis (1:100, Santa Cruz Biotechnology), MMP-2, MMP-9 (1:1000, EMD Millipore Corporation), Klotho (R&D Systems), and β-actin (1:10,000, Abcam). Goat anti-mouse or goat anti-rabbit conjugated with horseradish peroxidase (1:3000–1:5000, Santa Cruz Biotechnology) was used as a secondary antibody and incubated for 1 h at room temperature. Specific proteins were detected by chemiluminescent methods using Amersham ECL Western blotting detection reagents (GE Healthcare, UK). Protein abundance on Western blots was captured using Chem-Doc (Bio-Rad) and quantified by densitometry using the Image lab software (Bio-Rad, Hercules, CA).
+ Open protocol
+ Expand
2

Tenocyte Marker Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Expression of the tenocyte markers scleraxis (Santa Cruz Biotechnology, Dallas, Texas, USA), collagen type I (Merck Millipore, Milano, Italy) and the proliferative marker PCNA (Santa Cruz Biotechnology, Dallas, Texas, USA) was assessed by immunofluorescence. Primary monoclonal antibodies were diluted at 1 : 200 in PBS-1% BSA and incubated with the sections for 2 h at room temperature. The secondary DyLight 488 antibody (KPL, Kirkegaard & Perry Laboratories, Maryland, USA), diluted at 1 : 100, was incubated for 1 h at room temperature. Stained sections were visualized with an Apotome fluorescence microscope (Zeiss). We collected digital images using a ×20 dry lens within 0–5 days after labeling.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!